1017 / 1983
EBRO
2017
• 6
th
leading cause of cancer-related mortality
• 8
th
most common cancer worldwide
• Worldwide >450,000 people are affected
• Overall 5-year survival 15-25%
• Diagnosis at advanced (metastatic) stages
• 30-40% present with resectable disease
• SCC is predominant type; in some western European
countries adenocarcinoma exceeds SCC
Epidemiology of esophageal cancer